scholarly article | Q13442814 |
P2093 | author name string | Oliver Sartor | |
Charles L Bennett | |||
Kenneth R Carson | |||
Scott D Newsome | |||
P2860 | cites work | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 |
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project | Q33383576 | ||
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project | Q37568787 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
progressive multifocal leukoencephalopathy | Q704930 | ||
non-Hodgkin lymphoma | Q1138590 | ||
P304 | page(s) | 4006-4007 | |
P577 | publication date | 2014-08-13 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab | |
P478 | volume | 120 |
Q39705818 | Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system | cites work | P2860 |
Search more.